Safety of medicines used for ADHD in children: a review of published prospective clinical trials
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Safety of medicines used for ADHD in children: a review of published prospective clinical trials
Authors
Keywords
-
Journal
ARCHIVES OF DISEASE IN CHILDHOOD
Volume 99, Issue 9, Pages 866-872
Publisher
BMJ
Online
2014-04-20
DOI
10.1136/archdischild-2013-304170
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long-Term Treatment with Atomoxetine for Attention-Deficit/Hyperactivity Disorder Symptoms in Children and Adolescents with Autism Spectrum Disorder: An Open-Label Extension Study
- (2013) Myriam Harfterkamp et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Practitioner Review: Current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents
- (2013) Samuele Cortese et al. JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY
- Adverse event assessment, analysis, and reporting in recent published analgesic clinical trials: ACTTION systematic review and recommendations
- (2013) Shannon M. Smith et al. PAIN
- Reducing overdiagnosis and disease mongering in ADHD in Lombardy
- (2013) M. Bonati et al. BMJ-British Medical Journal
- Do prescription stimulants increase the risk of adverse cardiovascular events?: A systematic review
- (2012) Arthur N Westover et al. BMC Cardiovascular Disorders
- Risk of Serious Cardiovascular Problems with Medications for Attention-Deficit Hyperactivity Disorder
- (2012) Jose Martinez-Raga et al. CNS DRUGS
- P.7.a.012 Effects of OROS methylphenidate (OROS MPH) treatment in children and adolescents with ADHD, mental retardation and epilepsy
- (2012) A. Kesic et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Safety of Attention-Deficit/Hyperactivity Disorder Medications in Children: An Intensive Pharmacosurveillance Monitoring Study
- (2012) Simona Ruggiero et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Lower IQ is Associated with Decreased Clinical Response to Atomoxetine in Children and Adolescents with Attention-Deficit Hyperactivity Disorder
- (2011) Luigi Mazzone et al. CNS DRUGS
- Effect of transitioning from extended-release methylphenidate onto osmotic, controlled-release methylphenidate in children/adolescents with ADHD: results of a 3-month non-interventional study
- (2011) Christian Wolff et al. CURRENT MEDICAL RESEARCH AND OPINION
- Systematic review of safety in paediatric drug trials published in 2007
- (2011) Khairun Nain Bin Nor Aripin et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- One-year prospective follow-up of pharmacological treatment in children with attention-deficit/hyperactivity disorder
- (2011) Anna Didoni et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- ADHD: Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
- (2011) PEDIATRICS
- The occurrence of adverse drug reactions reported for attention deficit hyperactivity disorder (ADHD) medications in the pediatric population: a qualitative review of empirical studies
- (2011) Lise Aagaard et al. Neuropsychiatric Disease and Treatment
- Low quality of reporting adverse drug reactions in paediatric randomised controlled trials
- (2010) T. W. de Vries et al. ARCHIVES OF DISEASE IN CHILDHOOD
- A systematic review of safety monitoring and drug toxicity in published randomised controlled trials of antiepileptic drugs in children over a 10-year period
- (2010) M. Anderson et al. ARCHIVES OF DISEASE IN CHILDHOOD
- European guidelines on managing adverse effects of medication for ADHD
- (2010) J. Graham et al. EUROPEAN CHILD & ADOLESCENT PSYCHIATRY
- Adverse drug reactions in childhood: a review of prospective studies and safety alerts
- (2009) A Clavenna et al. ARCHIVES OF DISEASE IN CHILDHOOD
- Long-term tolerability of the methylphenidate transdermal system in pediatric attention-deficit/hyperactivity disorder: A multicenter, prospective, 12-month, open-label, uncontrolled, phase III extension of four clinical trials
- (2009) Robert L. Findling et al. CLINICAL THERAPEUTICS
- A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of Methylphenidate Transdermal System in Pediatric Patients With Attention-Deficit/Hyperactivity Disorder
- (2009) Robert L. Findling et al. JOURNAL OF CLINICAL PSYCHIATRY
- Safety and Tolerability of Atomoxetine Over 3 to 4 Years in Children and Adolescents With ADHD
- (2009) Craig Donnelly et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- The MTA at 8 Years: Prospective Follow-up of Children Treated for Combined-Type ADHD in a Multisite Study
- (2009) Brooke S.G. Molina et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- Adverse Effects of Pharmacotherapies for Attention-Deficit Hyperactivity Disorder
- (2008) Johnny Graham et al. CNS DRUGS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now